Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Nevo, Ori ^a   Lee, Dennis K ^a   Caniggia, Isabella ^b,c  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLT1 PROTEIN, HUMAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PROTEIN BINDING; PROTEIN KINASE B; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANOXIA; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PLACENTA; PREECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE;

ANOXIA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; OXYGEN; PHOSPHORYLATION; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84894189563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081176     Document Type: Article

References (28)

1. Maynard SE, Min JY, Merchan J, Lim KH, Li J, et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658. (Pubitemid 36278583)
2. Takahashi H and Shibuya M (2005) The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109: 227-241. (Pubitemid 41337127)
3. Heydarian M, McCaffrey T, Florea L, Yang Z, Ross MM, et al. (2009) Novel splice variants of sFlt1 are upregulated in preeclampsia. Placenta 30: 250-255.
4. Sela S, Itin A, Natanson-Yaron S, Greenfield C, Goldman-Wohl D, et al. (2008) A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia. Circ Res 102: 1566-1574.
5. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, et al. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677-1683. (Pubitemid 21924273)
6. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, et al. (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9: 936-943. (Pubitemid 36889938)
7. Kendall RL, Wang G, Thomas KA (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226: 324-328. (Pubitemid 26331903)
8. Neagoe PE, Lemieux C, Sirois MG (2005) Vascular endothelial growth factor (VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and -2 heterodimer. J Biol Chem 280: 9904-9912. (Pubitemid 40395838)
9. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55: 5687-5692.
10. Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, et al. (2002) Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160: 1405-1423. (Pubitemid 34411644)
11. Olszewska-Pazdrak B, Hein TW, Olszewska P, Carney DH (2009) Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells. Am J Physiol Cell Physiol 296: C1162-C1170.
12. Takagi H, King GL, Ferrara N, Aiello LP (1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 37: 1311-1321. (Pubitemid 26177307)
13. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, et al. (2006) Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 291: R1085-R1093. (Pubitemid 44498450)
14. ACOG (2002)ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 99: 159-167.
15. Soleymanlou N, Wu Y, Wang JX, Todros T, Ietta F, et al. (2005) A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ 12: 441-452. (Pubitemid 40662842)
16. Ray JE, Garcia J, Jurisicova A, Caniggia I (2010) Mtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsia. Cell Death Differ 17: 846-859.
17. Macphee DJ, Mostachfi H, Han R, Lye SJ, Post M, et al. (2001) Focal adhesion kinase is a key mediator of human trophoblast development. Lab Invest 81: 1469-1483. (Pubitemid 33064274)
18. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, et al. (2008) Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 93: 285-292.
19. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, et al. (2000) Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157: 2111-2122.
20. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, et al. (2001) Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 7: 205-210. (Pubitemid 32148349)
21. Marini M, Vichi D, Toscano A, Zappoli Thyrion GD, Parretti E, et al. (2007) Expression of vascular endothelial growth factor receptor types 1, 2 and 3 in placenta from pregnancies complicated by hypertensive disorders. Reprod Fertil Dev 19: 641-651. (Pubitemid 47026666)
22. Schiessl B, Innes BA, Bulmer JN, Otun HA, Chadwick TJ, et al. (2009) Localization of angiogenic growth factors and their receptors in the human placental bed throughout normal human pregnancy. Placenta 30: 79-87.
23. Ulyatt C, Walker J, Ponnambalam S (2011) Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells. Biochem Biophys Res Commun 404: 774-779.
24. Gerber HP, Condorelli F, Park J, Ferrara N (1997) Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272: 23659-23667. (Pubitemid 27410939)
25. Waltenberger J, Mayr U, Pentz S, Hombach V (1996) Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94: 1647-1654. (Pubitemid 26320271)
26. Huang K, Andersson C, Roomans GM, Ito N, Claesson-Welsh L (2001) Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int J Biochem Cell Biol 33: 315-324. (Pubitemid 32324000)
27. Cudmore MJ, Hewett PW, Ahmad S, Wang KQ, Cai M, et al. (2012) The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis. Nat Commun 3: 972.
28. Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nor JE (2010) VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death Differ 17: 499-512.